HOFFMANN-LA ROCHE INC. v. Mason

Appellants, Hoflman-La Roche Inc. and Roche Laboratories Inc., challenge a final money judgment in favor of Appellee, Adam W. Mason, awarding Appellee compensatory damages after a jury found that Appellants placed Accutane on the market with an inadequate warning to Appellee’s physicians about the risk of developing inflammatory bowel disease (“IBD”), and that the failure to provide an adequate warning was a substantial contributing cause of Appellee’s development of IBD. Because Appellee presented no evidence from either treating physician that a differently worded warning would have…